SHANI C KOTADIA

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TUCSON, AZ NPI 1619256807

General Payments — all program years on this page

$1,696.94

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.37 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $298.0516
Education $5.322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $53.895
2019 $213.9813
2020 $29.972
2021 $366.1320
2022 $551.9525
2023 $177.659
2024 $303.3718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086144857 Bayer Healthcare Pharmaceuticals Inc. $14.08 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086152347 Bayer Healthcare Pharmaceuticals Inc. $15.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086254850 Bayer Healthcare Pharmaceuticals Inc. $14.73 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086256810 Bayer Healthcare Pharmaceuticals Inc. $15.36 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096761373 Novo Nordisk Inc $18.70 08/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097460475 Novo Nordisk Inc $20.03 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104571294 AstraZeneca Pharmaceuticals LP $19.02 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104736619 AstraZeneca Pharmaceuticals LP $24.55 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115828740 Amgen Inc. $18.79 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116484885 GlaxoSmithKline, LLC. $19.64 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117601885 Amgen Inc. $18.85 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118081292 Boehringer Ingelheim Pharmaceuticals, Inc. $17.98 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118081294 Boehringer Ingelheim Pharmaceuticals, Inc. $18.53 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118081296 Boehringer Ingelheim Pharmaceuticals, Inc. $26.34 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118924545 Otsuka America Pharmaceutical, Inc. $17.34 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149912148 Travere Therapeutics, Inc. $2.66 01/18/2024 Education Undisputed 01/23/2026 View at CMS
1149912152 Travere Therapeutics, Inc. $2.66 01/19/2024 Education Undisputed 01/23/2026 View at CMS
1149912156 Travere Therapeutics, Inc. $18.33 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.